Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
As of today (2026-08-06), the Forward Annual Dividend Yield of AbbVie is 0.00%.
As of today (2026-08-06), the Trailing Annual Dividend Yield of AbbVie is 0.00%.
XSGO:ABBVCL's Forward Dividend Yield % is not ranked *
in the Drug Manufacturers industry.
Industry Median: 2.04 * Ranked among companies with meaningful Forward Dividend Yield % only.
During the past 12 months, AbbVie's average Dividends Per Share Growth Rate was 5.60% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was 5.20% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 6.60% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 13.10% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of AbbVie was 23.40% per year. The lowest was 5.20% per year. And the median was 12.80% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
XSGO:ABBVCL vs MRK, JNJ, AMGN: Forward Dividend Yield % Comparison
For the Drug Manufacturers - General subindustry, AbbVie's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AbbVie Forward Dividend Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, AbbVie's Forward Dividend Yield % distribution charts can be found below:
* The bar in red indicates where AbbVie's Forward Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
AbbVie Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 1.730000
2026-07-15
2026-07-15
2026-08-14
Cash Dividend
quarterly
USD:CLP 905.438618
USD 1.730000
2026-04-15
2026-04-15
2026-05-15
Cash Dividend
quarterly
USD:CLP 898.301568
USD 1.730000
2026-01-16
2026-01-16
2026-02-17
Cash Dividend
quarterly
USD:CLP 882.682968
USD 1.640000
2025-10-15
2025-10-15
2025-11-14
Cash Dividend
quarterly
USD:CLP 952.667409
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
AbbVie's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
6209.88660718
/
171590.00
=
3.62 %
Current Share Price is CLP171590.00. AbbVie's Dividends per Share for the trailing twelve months (TTM) ended in Today is CLP6209.88660718.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Forward Dividend Yield % of 0.00% mean?
AbbVie (XSGO:ABBVCL) has a Forward Dividend Yield % of 0.00% as of Aug. 06, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on AbbVie and its competitors. According to the industry distribution chart, AbbVie ranks #185 out of 510 companies in the Drug Manufacturers industry, placing it in the top 36.3%.
Is AbbVie's Forward Dividend Yield % too high?
AbbVie's current Forward Dividend Yield % is 0.00%. Based on the distribution chart, AbbVie ranks #185 out of 510 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, AbbVie has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does AbbVie's Forward Dividend Yield % compare to MRK and JNJ?
According to the Drug Manufacturers industry distribution chart, AbbVie ranks #185 out of 510 companies for Forward Dividend Yield %. This puts AbbVie in the upper half of its industry. The industry median Forward Dividend Yield % is 2.04. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Drug Manufacturers company?
The median Forward Dividend Yield % among Drug Manufacturers companies is 2.04, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on AbbVie and its competitors. For the Drug Manufacturers industry, the median Forward Dividend Yield % is 2.04 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AbbVie's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AbbVie stock overvalued right now?
AbbVie (XSGO:ABBVCL) has a current Forward Dividend Yield % of 0.00%. The stock's GF Value™ is CLP151,782.58, compared to a current price of CLP171,590.00 — trading 13% above its estimated fair value. The current Forward Dividend Yield % is 0.00%. AbbVie's overall GF Score™ is 77/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For AbbVie (XSGO:ABBVCL), the current Forward Dividend Yield % is 0.00% as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AbbVie (XSGO:ABBVCL) Overvalued in 2026?
Based on GuruFocus' analysis, AbbVie stock appears to be overvalued.
The current stock price of CLP171,590.00 is trading 13% above its estimated GF Value™ of CLP151,782.58.
Key valuation signals for XSGO:ABBVCL:
Forward Dividend Yield %: 0.00%
GF Value™: CLP151,782.58 vs. price of CLP171,590.00 (13% above fair value)
No single metric tells the full story. See the XSGO:ABBVCL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics, including Botox. The 2024 acquisitions of Cerevel (neuroscience) and ImmunoGen (oncology) help supplement AbbVie's portfolio.
77GF Score
Get the complete analysis for XSGO:ABBVCL
Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSGO:ABBVCL has been successfully added to your 
